Abstract
A FGFR4 Gly388Arg polymorphism (rs351855) which caused the substitution of arginine for glycine in the transmembrane domain of the receptor, was reported to increase cancer risk or not. According to this reason, a meta analysis was made, including a total of 4767 cases and 5817 controls. The results showed that FGFR4 Gly388Arg polymorphism (rs351855) might be an cancer risk factor for majority Asians, especially in breast cancer and prostate cancer. But it was necessary to complete several large samples studies of various type cancers from different ethnic populations.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
